Insider Trading April 6, 2026

Lands' End Director Disposes of 935 Shares as Company Reports Q4 Shortfalls and $100M Buyback Authorization

Elizabeth Leykum sold $42,075 in stock tied to a LEWHP, LLC tender offer as Lands' End posts modest revenue growth but misses EPS and sales expectations

By Priya Menon LE
Lands' End Director Disposes of 935 Shares as Company Reports Q4 Shortfalls and $100M Buyback Authorization
LE

Elizabeth Leykum, a member of Lands' End Inc.'s board, sold 935 shares on April 1, 2026, in a transaction tied to a tender offer, generating $42,075. The sale occurred at $45.00 per share, well above the company's prevailing market price of $10.90. Lands' End reported fiscal 2025 fourth-quarter results that missed analyst projections on both earnings and revenue, while total revenue rose 5% year-over-year. The board meanwhile approved a share repurchase program of up to $100 million through March 31, 2029.

Key Points

  • Director Elizabeth Leykum sold 935 shares on April 1, 2026, at $45.00 per share, totaling $42,075.
  • Lands' End reported Q4 fiscal 2025 EPS of $0.76 and revenue of $462.4 million, missing projections; total revenue rose 5% year-over-year.
  • The board approved a share repurchase program of up to $100 million, effective through March 31, 2029; repurchases may be made via open market, private transactions, or other permitted methods.

Elizabeth Leykum, a director at LANDS' END, INC. (NASDAQ: LE), executed a sale of 935 shares of the company's common stock on April 1, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at $45.00 apiece, producing gross proceeds of $42,075.

The per-share sale price in this transaction is substantially higher than Lands' End's quoted market price of $10.90. The company's stock has declined 30% over the past six months and is down 25% year-to-date, based on the price cited in the filing.

After completing the sale, Leykum continues to hold a direct stake of 11,364 shares through By Serenade Capital LLC. The filing specifies that the disposition was made pursuant to a tender offer by LEWHP, LLC. The Form 4 was signed on Leykum's behalf by Peter L. Gray, acting as attorney-in-fact.


Separately, Lands' End released its fourth-quarter results for the fiscal year 2025. The company reported earnings per share of $0.76, which fell short of the $0.79 that had been projected. Revenue for the quarter totaled $462.4 million, missing the anticipated $472.24 million estimate. The company did note, however, that total revenue increased by 5% compared with the same quarter in the prior fiscal year.

In conjunction with those results, Lands' End's board of directors authorized a share repurchase program of up to $100 million, effective through March 31, 2029. The company stated that repurchases may be carried out through open market purchases, privately negotiated transactions, or by other methods permitted under federal securities laws. The timing and size of any repurchases will depend on a variety of factors, including the share price, availability of shares, trading volume, and market conditions.

Investment analysis noted in the filing indicates that some assessments view the stock as potentially undervalued at current levels, and that additional analytical guidance is available in the form of extra ProTips. The filing and the company disclosures together outline both a board-level response to the current share price environment and a recent insider disposition tied to a tender offer.


These developments combine an insider sale tied to a third-party tender offer, a quarterly earnings and revenue miss, modest year-over-year revenue growth, and a sizeable board-authorized buyback program. Taken together, they represent discrete corporate actions and reported results that market participants can weigh as they assess Lands' End's near-term outlook.

Risks

  • Market valuation uncertainty reflected in a stock price that has fallen 30% over six months and 25% year-to-date, which may affect investor sentiment and liquidity.
  • Operational or financial performance risk signaled by quarterly results that missed projections on both earnings per share and revenue.
  • Execution and timing risk related to the $100 million buyback authorization, which depends on share price, availability, trading volume, and market conditions.

More from Insider Trading

Power Integrations VP Sells 313 Shares to Cover Tax Bill; Stock Up 45% YTD Apr 6, 2026 Lipocine Director Purchases 123,000 Shares Amid Mixed Clinical News Apr 6, 2026 Kinder Morgan Vice President Disposes of $203K in Class P Shares Apr 6, 2026 RA Capital Disposes $14.5M of Vor Biopharma Stock Across Early April Trades Apr 6, 2026 Magnetar Financial Disposes of 23,088 Wheeler Real Estate Shares for About $21.5k Apr 6, 2026